What is the recommended treatment for whooping cough (pertussis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Whooping Cough Treatment

Azithromycin is the first-line treatment for pertussis across all age groups, with a 5-day course (10 mg/kg on day 1, then 5 mg/kg daily on days 2-5 for children; 500 mg on day 1, then 250 mg daily on days 2-5 for adults) being as effective as 14 days of erythromycin while causing significantly fewer gastrointestinal side effects and improving compliance. 1, 2

First-Line Antibiotic Therapy

Azithromycin Dosing by Age

  • Infants <1 month: 10 mg/kg per day for 5 days (preferred over erythromycin due to lower risk of infantile hypertrophic pyloric stenosis) 1
  • Infants 1-5 months: 10 mg/kg per day for 5 days 1
  • Children ≥6 months: 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg per day (maximum 250 mg) on days 2-5 1
  • Adults: 500 mg on day 1, followed by 250 mg per day on days 2-5 1

Alternative Macrolides

  • Clarithromycin is equally effective as azithromycin and can be used as first-line therapy, particularly in infants 1-5 months of age 1
  • Dosing: 15 mg/kg per day divided into two doses for 7 days in children; 500 mg twice daily for 7 days in adults 3

Second-Line Option

  • Trimethoprim-sulfamethoxazole (TMP-SMZ) for patients >2 months with macrolide contraindications (hypersensitivity to any macrolide agent) 1, 4

Timing of Treatment: Critical for Effectiveness

Start antibiotics immediately upon clinical suspicion—do not wait for culture confirmation. 5

  • Early treatment (catarrhal phase, first 2 weeks): Rapidly clears B. pertussis from the nasopharynx, decreases coughing paroxysms, and reduces complications 5
  • Late treatment (paroxysmal phase, >3 weeks): Limited clinical benefit but still indicated to prevent transmission 5
  • Approximately 80-90% of untreated patients spontaneously clear bacteria within 3-4 weeks from cough onset 1

Isolation Requirements

  • Isolate patients at home and away from work/school for 5 days after starting antibiotics 5
  • Without treatment, patients remain infectious for approximately 3 weeks after cough onset 3

Post-Exposure Prophylaxis

Use the same antibiotic regimens and dosing as for treatment. 1, 3

Who Should Receive Prophylaxis

  • All household contacts regardless of age or vaccination status 3
  • High-priority contacts: Infants <12 months (especially <4 months), pregnant women in third trimester 1, 3
  • Administer within 21 days of exposure for effectiveness 3

Rationale

  • Pertussis has a secondary attack rate exceeding 80% among susceptible household contacts 3
  • Prophylaxis aims to eradicate B. pertussis from the nasopharynx of infected persons (symptomatic or asymptomatic) and create a protective "cocoon" around vulnerable infants 6, 3

Evidence Supporting Azithromycin Superiority

  • A large multicenter randomized trial demonstrated 100% bacterial eradication with both azithromycin (5 days) and erythromycin (14 days), but azithromycin caused significantly fewer gastrointestinal adverse events (18.8% vs 41.2%) 2
  • Compliance was markedly superior with azithromycin: 90% of children took 100% of prescribed doses versus only 55% with erythromycin 2
  • Cochrane systematic review confirmed short-term antibiotics (azithromycin 3 days, clarithromycin 7 days) were equally effective as 14-day erythromycin with fewer side effects (RR 0.66; 95% CI 0.52-0.83) 7

Important Medication Considerations

Azithromycin Precautions

  • Do not administer simultaneously with aluminum- or magnesium-containing antacids (reduces absorption) 1
  • Use with caution in patients with impaired hepatic function 1
  • Monitor for drug interactions with agents metabolized by cytochrome P450 (digoxin, triazolam, ergot alkaloids) 1

Erythromycin Warnings

  • Associated with infantile hypertrophic pyloric stenosis (IHPS) in infants <1 month—avoid if possible 1, 6
  • If erythromycin must be used: 40-50 mg/kg/day in children, 1-2 g per day in adults for 14 days 5, 4
  • Erythromycin resistance is rare (<1%) 5

Therapies That Do NOT Work

  • Long-acting β-agonists, antihistamines, corticosteroids, and pertussis immunoglobulin have no significant benefit in controlling coughing paroxysms 5

Common Pitfalls to Avoid

  • Delaying treatment while awaiting culture results: Start antibiotics immediately based on clinical suspicion (cough >2 weeks with paroxysms, post-tussive vomiting, or inspiratory whoop) 5
  • Failing to provide prophylaxis to household contacts: This is critical to prevent severe disease in vulnerable infants 3
  • Using erythromycin in young infants: Azithromycin is safer due to lower IHPS risk 1, 6
  • Expecting antibiotics to stop established paroxysms: Antibiotics eliminate bacteria and prevent transmission but do not alter the clinical course once paroxysmal coughing is established 7, 2

References

Guideline

Treatment of Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Post-Exposure Prophylaxis for Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prophylactic Antibiotics for Infants with Parents Exposed to Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotics for whooping cough (pertussis).

The Cochrane database of systematic reviews, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.